Case Comprehensive Cancer Center: Melanoma trials

The registry lists 11 Melanoma studies with Case Comprehensive Cancer Center as lead sponsor. 0 are open to participants now and 2 have results posted.

Early Phase 1 2Phase 1 3Phase 2 4No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness GenesCompletedNCT04187833Phase 2Results posted
• Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic ImbalanceCompletedNCT01100528Phase 2Results posted
• Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma SettingCompletedNCT05079113
• Prevention of Recurrence and Metastasis in Genetically High-Risk MelanomasWithdrawnNCT04285749Early Phase 1
• A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor PatientsWithdrawnNCT02661100Phase 1/2
• Ex Vivo-Activated Lymph Node Lymphocytes in Treating Patients With Stage IIIC-IV MelanomaTerminatedNCT02327390Phase 1
• Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver MetastasesTerminatedNCT01730157Early Phase 1
• Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant MelanomaTerminatedNCT00991991
• Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the EyeCompletedNCT00952939
• Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other CancersCompletedNCT00498979Phase 1
• Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular MelanomaCompletedNCT00085306Phase 2